Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death

Virology

Volumn 218, Issue 1, 1996, Pages 181-192

  Callebaut, Christian ^a   Jacotot, Etienne ^a   Guichard, Gilles ^b   Krust, Bernard ^a   Rey Cuille, Marie Anne ^a   Cointe, Denis ^a   Benkirane, Nadia ^b   Blanco, Julià ^a   Muller, Sylviane ^b   Briand, Jean Paul ^b   Hovanessian, Ara G ^a  

^a CNRS   (France)

^b INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SYNTHETIC PEPTIDE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMBRANE FUSION; PRIORITY JOURNAL; SYNCYTIUM; VIRUS INHIBITION;

EID: 17944394280     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0178     Document Type: Article

References (52)

1. Avril, L. E., Di Martino-Ferrer, M., Pignede, G., Seman, M., and Gauthier, F. (1994). Identification of the U-937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gp120 as cathepsin G. FEBS Lett. 345, 81-86.
2. Bauvois, B., Sanceau, J., and Wietzerbin, J. (1992). Human U937 cell surface peptidase activities: Characterization and degradative effect on tumor necrosis factor-α. Eur. J. Immunol. 22, 923-930.
3. Benjouad, A., Chapuis, F., Fenouillet, E., and Gluckman, J.-C. (1995). Multibranched peptide constructs derived from the V3 loop of envelope glycoprotein gp120 inhibit human immunodeficiency virus type 1 infection through interaction with CD4. Virology 206, 457-464.
4. Brandt, W., Lehmann, T., Hofmann, T., Schowen, R. L., and Barth, A. (1992). The probable conformation of substrates recognized by dipeptidyl-peptidase IV and some aspects of the catalytic mechanism derived from theoretical investigations. J. Computer-Aided Mol. Design 6, 159-174.
5. Broder, C., Nussbaum, O., Gutheil, W. G., Bachovchin, W. W., Berger, E. A., Patience, C., McKright, A., Clapham, P. R., Boyd, M. T., Weiss, R. A., Schulz, T. F., Camerini, D., Planelles, V., Chen, I. S. Y., Alizon, M., and Dragic, T. (1994). CD26 antigen and HIV fusion? Science 264, 1156-1162. [Technical Comments]
6. Buckheit, R. W., Roberson, J. L., Lackman-Smith, C., Wyatt, J. R., Vickers, T. A., and Ecker, D. J. (1994). Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320). AIDS Res. Hum. Retroviruses 11, 1497-1506.
7. + cells. Science 262, 2045-2050.
8. Callebaut, C., Jacotot, E., Marie, I., Blank, U., Robert, N., Krust, B., and Hovanessian, A. (1994a). The role of CD26 in HIV infection: Viral entry and its cytopathic effect. In "9° Colloque des Cent Gardes: Retrovirus of Human AIDS and Related Animal Diseases" (M. Girard and B. Dodet, Eds.), pp. 141-149. Marnes-La-Coquette, Paris.
9. Callebaut, C., Jacotot, E., Krust, B., and Hovanessian, A. G. (1994b). CD26 antigen and HIV fusion? Response. Science 264, 1162-1165. [Technical Comments]
10. Chesebro, B., Wehrly, K., Nishio, J., and Perryman, S. (1992). Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism. J. Virol. 66, 6547-6554.
11. Chin, L. T., Duenas, M., Levi, M., Hinkula, J., Wahren, B., and Borrebaeck, C. A. K. (1995). Molecular characterization of a human anti-HIV 1 monoclonal antibody revealed a CD26-related motif in CDR2. Immunol. Lett. 44, 25-30.
12. Corbeau, P., Olive, D., and Devaux, C. (1991). Anti-HLA class-I heavy chain monoclonal antibodies inhibit human immunodeficiency virus production by peripheral blood mononuclear cells. Eur. J. Immunol. 21, 865-871.
13. + T cells. J. Gen. Virol. 76, 681-690.
14. Daniel, M. D., Letvin, N. L., King, N. W., Kannagi, M., Sehgal, P. K., Hunt, R. D., Kanki, P. J., Essex, M., and Desrosiers, R. C. (1985). Isolation of a T-cell tropic HTLVIII-like retrovirus from macaques. Science 228, 1201-1204.
15. Dawson, P. E., and Kent, S. B. H. (1993). Convenient total synthesis of a 4-helix TASP molecule by chemoselective ligation. J. Am. Chem. Soc. 115, 7263-7266.
16. De Jong, J. J., De Ronde, A., Keulen, W., Tersmette, M., and Goudsmit, J. (1992). Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: Analysis by single amino acid substitution. J. Virol. 66, 6777-6780.
17. Dragic, T., Chameau, P., Clavel, F., and Alizon, M. (1992). Complementation of murine cells for human immunodeficiency virus envelope/ CD4-mediated fusion in human/murine heterokaryons. J. Virol. 66, 4794-4802.
18. Dukes, C. S., Yu, Y., Rivadeneira, E. D., Sauls, D. L., Liao, H. K., Haynes, B. F., and Weinberg, J. B. (1995). Cellular CD44S as a determinant of human immunodeficiency virus type 1 infection and cellular tropism. J. Virol. 69, 4000-4005.
19. Freed, E. O., Myers, D. J., and Risser, R. (1991). Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain. J. Virol. 65, 190-194.
20. Grimalia, R. J., Fuller, B. A., Rennert, P. D., Nelson, M. B., Hammarskjold, M. L., Potts, B., Murray, M., Putney, S. D., and Gray, G. (1992). Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation virus infectivity, growth kinetics, and neutralization. J. Virol. 66, 1875-1883.
21. Guichard, G., Briand, J. P., and Friede, M. (1993). Synthesis of arginine aldehyde for the preparation of pseudopeptides. Pept. Res. 6, 121-124.
22. Guichard, G., Calbo, S., Muller, S., Kourilsky, P., Briand, J. P., and Abastado, J. P. (1995). J. Biol. Chem. 270, 26057-26060.
23. Hattori, T., Koito, A., Takatsuki, K., Kido, H., and Katunuma, N. (1989). Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection. FEBS Lett. 248, 48-52.
24. Hovanessian, A. G. (1994). Apoptosis in HIV infection: The role of extracellular and transmembrane glycoproteins. In "Apoptosis II:The Molecular Basis of Apoptosis in Disease," pp. 21-42. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
25. Kemp, D. S. (1990). Peptidomimetics and the template approach to nucleation of β-sheets and α-helices in peptides. Trends Biotechnol. 8, 249-255.
26. + lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HIV-1: Purification and characterization. J. Biol. Chem. 265, 21979-21985.
27. Laurent-Crawford, A. G., and Hovanessian, A. G. (1993). The cytopathic effect of human immunodeficiency virus is independent of high levels of unintegrated viral DNA accumulated in response to superinfection of cells. J. Gen. Virol. 74, 2619-2628.
28. Laurent-Crawford, A. G., Krust, B., Riviere, Y., Desgranges, C., Muller, S., Kieny, M. P., Dauguet, C., and Hovanessian, A. G. (1993). Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res. Hum. Retroviruses 9, 761-773.
29. + target cells. Res. Virol. 146, 5-17.
30. Maldarelli, F., Sato, H., Berthold, E., Orenstein, J., and Martin, M. A. (1995). Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1. J. Virol. 69, 6457-6465.
31. Mann, D. L., Read-Connole, E., Arthur, L., Robey, W. G., Wernet, P., Schneider, E. M., Blattner, W. A., and Popovic, M. (1988). HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class-II antigens. J. Immunol. 141, 1131-1136.
32. Moore, J. P., and Nara, P. L. (1991). The role of the V3 loop of gp120 in HIV infection. AIDS 5, S21-S33.
33. Moore, J. P., Jameson, B. A., Weiss, R. A., and Sattentau, Q. J. (1993). The HIV-cell fusion reaction. In "Viral Fusion Mechanisms" (J. Bentz, Ed.), pp. 233-289. CRC Press, Boca Raton, FL.
34. Mutter, M. (1985). The construction of new proteins and enzymes - A prospect for the future? Chem. Int. Ed. Engl. 24, 639-653.
35. Myers, G., Korber, B., Wain-Hobson, S., Jeang, K-T., Henderson, L. E., and Pavlakis, G. N. (Eds.) (1994). "Human Retroviruses and AIDS 1994." Theoretical Biology and Biophysics Group T-10, Los Alamos National Laboratory, Los Alamos, NM.
36. Neimark, J., and Briand, J. P. (1993). Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavage capability. Pept. Res. 6, 219-228.
37. Oravecz, T., Roderiquez, G., Koffi, J., Wang, J., Ditto, M., Bou-Habib, D. C., Lusso, P., and Norcross, M. A. (1995). CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line. Nature Med. 1, 919-926.
38. Osmanov, S., Heyward, W. L., and Esparza, J. (1994). The World Health Organization Network for HIV isolation and characterization: Summary of a pilot study. AIDS Res. Hum. Retroviruses 10, 1325-1326.
39. Rahfeld, J., Schierhorn, M., Hartrodt, B., Neubert, K., and Heins, J. (1991). Are diprotin A(lle-Pro-lle) and diprotin B (Val-Pro-Leu) inhibitors or substrates of dipepidyl peptidase IV? Biochem. Biophys. Acta 1076, 314-316.
40. Rao, P. R., Talle, M. A., Kung, P. C., and Goldstein, G. (1983). Five epitopes of a differentiation antigen on human inducer T cells distinguished by monoclonal antibodies. Cell. Immunol. 80, 310-319.
41. Resnick, L., Markham, P., Veren, K., Salahuddin, S. Z., and Gallo, R. C. (1986). In vitro suppression of HTLV-III/LAV infectivity by a combination of acyclovir and suramin. J. Infect. Dis. 154, 1027-1030.
42. Rey-Cuillé, M. A., Galabru, J., Laurent-Crawford, A., Krust, B., Montagnier, L., and Hovanessian, A. G. (1994). HIV-2 EHO isolate has a divergent env gene and induces single cell killing by apoptosis. Virology 202, 471-476.
43. 2NH peptide isostere. Peptides 8, 119-121.
44. Sato, A. I., Balamuth, F. B., Ugen, K. E., Williams, W. V., and Weiner, D. B. (1994). Identification of CD7 glycoprotein as an accessory molecule in HIV-1 mediated syncytium formation and cell free infection. J. Immunol. 152, 5142-5152.
45. Sattentau, Q. J., and Weiss, R. A. (1988). The CD4 antigen: Physiological ligand and HIV receptor. Cell 52, 631-633.
46. Schwartz, O., Henin, Y., Marechal, V., and Montagnier, L. (1988). A rapid and simple colorimetric test for the study of anti-HIV agents. AIDS Res. Hum. Retroviruses 4, 441-448.
47. Tuschscherer, G., and Mutter, M. (1995). Protein design as a challenge for peptide chemist. J. Pept. Sci. 1, 3-10.
48. Umezawa, H., Aoyagi, T., Ogawa, K., Naganawa, H., Hamada, M., and Takeuchi, T. (1984). Diprotins A and B, inhibitors of dipeptidyl amino-peptidase IV, produced by bacteria. J. Antibiot. 37, 422-425.
49. Wain-Hobson, S., Vartanian, J. P., Henry, M., Chenciner, N., Cheynier, R., Delassus, S., Martins, L. P., Sala, M., Nugeyre, M. T., Guetard, D., Klatzmann, D., Gluckman, J. C., Rozenbaum, W., Barre-Sinoussi, F., and Montagnier, L. (1991). LAV revisited: Origins of the early HIV-1 isolates from Institut Pasteur. Science 252, 961-965.
50. Xu, Y., Murakami, T., Kawase, S., Uchiyama, T., and Hattori, T. (1995). Characterization of V3 loop-binding protein(s) of Molt-4 and U937 cells. AIDS Res. Hum. Retroviruses 11, 563-570.
51. Yahi, S., Fantini, J., Mabrouk, K., Tamalet, C., De Micco, P., Van Rietschoten, J., Rochat, H., and Sabatier, J.-M. (1994). Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages. J. Virol. 68, 5714-5720.
52. Yaron, A., and Naider, F. (1993). Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol. 28, 31-81.